La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Complication »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Complexe fluoro < Complication < Complément  Facettes :

List of bibliographic references indexed by Complication

Number of relevant bibliographic references: 47.
[0-20] [0 - 20][0 - 47][20-40]
Ident.Authors (with country if any)Title
000B94 (2014) Nicolas Morin [Canada] ; Vincent A. Jourdain ; Thérèse Di PaoloModeling dyskinesia in animal models of Parkinson disease : ANIMAL MODELS OF PARKINSON'S DISEASE
001038 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001860 (2011) Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne]Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting
001D20 (2010) Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada]Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
002298 (2008) Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]Neuropathy as a potential complication of levodopa use in Parkinson's disease
002308 (2008) Susan H. Fox [Canada] ; Anthony E. Lang [Canada]Levodopa‐related motor complications—Phenomenology
002525 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
002883 (2006) Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications
002936 (2006) Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France]Deep brain stimulation for Parkinson's disease : Surgical issues
002B05 (2005) Constantine Constantoyannis [Canada] ; Caglar Berk [Canada] ; Christopher R. Honey [Canada] ; Ivar Mendez [Canada] ; Robert M. Brownstone [Canada]Reducing hardware-related complications of deep brain stimulation
002B51 (2005) Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease
002C61 (2004) Fre De Ric Calon ; Mehdi Dridi ; Oleh Hornykiewicz [Autriche] ; Paul J. Be Dard [Canada] ; Ali H. Rajput ; The Re Se Di PaoloIncreased adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias
002D04 (2004) Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada]Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
002E76 (2003) Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada]Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study
002E93 (2003) Carlo Pappone [Italie] ; Vincenzo Santinelli [Italie] ; Salvatore Rosanio [Italie] ; Gabriele Vicedomini [Italie] ; Stefano Nardi [Italie] ; Alessia Pappone [Italie] ; Valter Tortoriello [Italie] ; Francesco Manguso [Italie] ; Patrizio Mazzone [Italie] ; Simone Gulletta [Italie] ; Giuseppe Oreto [Italie] ; Ottavio Alfieri [Canada] ; Derick M. Todd [Canada] ; George J. Klein [Canada] ; Andrew D. Krahn [Canada] ; Allan C. Skanes [Canada] ; Raymond Yee [Canada]Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-white pattern: Results from a large prospective long-term follow-up study. Commentary
002E95 (2003) Joseph King Ching Tsui [Canada]Treatment of dystonia in Parkinson's disease
002F04 (2003) Basta Maria [Grèce] ; Schiza Sophia [Grèce] ; Mauridis Michalis [Grèce] ; Lydakis Charalampos [Grèce] ; Plaitakis Andreas [Grèce] ; Milic Emili John [Canada] ; Siafakas M. Nikolaos [Grèce]Sleep breathing disorders in patients with idiopathic Parkinson's disease
002F08 (2003) Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis]Progression of gait, speech and swallowing deficits in progressive supranuclear palsy
002F22 (2003) Ajit Kumar [Canada] ; ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada]Mechanisms of motor complications in treatment of Parkinson's disease
002F44 (2003) Pierre J. Blanchet [États-Unis, Canada] ; Spiros Konitsiotis [États-Unis, Grèce] ; Hideki Mochizuki [États-Unis, Japon] ; Ryszard Pluta [États-Unis] ; Dwaine F. Emerich [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis]Complications of a trophic xenotransplant approach in parkinsonian monkeys
003033 (2002) Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical–Pathological study of levodopa complications

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Complication" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Complication" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Complication
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022